Patent details

EP3143998 Title: AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3143998
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16185402.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
06/12/2012
Grant date:
22/05/2019
EP Publication Date:
22/03/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/06/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/05/2019
EP B1 Publication Date:
22/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/12/2032
Lapsed By Expiration Date:
Patent Validated Date:
26/06/2019
Revocation Date:
29/05/2024
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/05/2019
 
 

 

Name:
Teva Branded Pharmaceutical Products R & D, Inc.
Address:
41 Moores Road, Frazer, Pennsylvania 19355, United States of America (US)

Agent

Name:
dr. A. Krebs
From:
25/06/2019
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Inventor

Name:
ZENG, Xian-Ming
Address:
Miami, FL Florida 33169-5043, United States of America (US)

Priority

1

Priority Patent Number:
201200525
Priority Date:
13/01/2012
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
201161577315 P
Priority Date:
19/12/2011
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/12; A61K 31/46; A61K 47/12; A61M 15/00; A61P 11/00; A61K 47/10;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
29/24
Publication date:
17/07/2024
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
26/19
Publication date:
26/06/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
21/19
Publication date:
22/05/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202429
Publication date:
17/07/2024
Description:
Revocation of the European patent

2

Issue number:
201921
Publication date:
22/05/2019
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
21/11/2023
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
25/06/2019 Outgoing Correspondence Letter no formal defects 1 PDF /9/2/8/4/1/0800414829/docs/ep16185402.1_1_282178l271.pdf
06/06/2019 Claims First filed claims 1 PDF /9/2/8/4/1/0800414829/docs/ep16185402.1_0_claims20190606094521441.pdf